Chemed Corp CHE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30
-
Chemed Corporation Declares Quarterly Dividend of 50 Cents
-
Chemed Reports Second-Quarter 2024 Results
-
Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25
Trading Information
- Previous Close Price
- $600.06
- Day Range
- $599.04–605.03
- 52-Week Range
- $497.37–654.62
- Bid/Ask
- $575.34 / $629.00
- Market Cap
- $8.98 Bil
- Volume/Avg
- 59,218 / 89,291
Key Statistics
- Price/Earnings (Normalized)
- 26.52
- Price/Sales
- 3.92
- Dividend Yield (Trailing)
- 0.28%
- Dividend Yield (Forward)
- 0.33%
- Total Yield
- 1.94%
Company Profile
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Growth
- Total Number of Employees
- 15,087
- Website
- https://www.chemed.com
Comparables
Valuation
|
Metric
|
CHE
|
CON
|
ADUS
|
|---|---|---|---|
Price/Earnings (Normalized) | 26.52 | 21.80 | 26.03 |
Price/Book Value | 7.45 | 2.28 | 2.57 |
Price/Sales | 3.92 | 1.53 | 1.92 |
Price/Cash Flow | 22.74 | 10.94 | 21.83 |
Price/Earnings
CHE
CON
ADUS
Financial Strength
|
Metric
|
CHE
|
CON
|
ADUS
|
|---|---|---|---|
Quick Ratio | 1.56 | 1.05 | 1.92 |
Current Ratio | 1.78 | 1.21 | 2.00 |
Interest Coverage | 228.70 | 2.58 | 9.00 |
Quick Ratio
CHE
CON
ADUS
Profitability
|
Metric
|
CHE
|
CON
|
ADUS
|
|---|---|---|---|
Return on Assets (Normalized) | 21.04% | 5.69% | 8.05% |
Return on Equity (Normalized) | 31.59% | 15.33% | 11.13% |
Return on Invested Capital (Normalized) | 27.08% | 10.32% | 10.09% |
Return on Assets
CHE
CON
ADUS
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| HCA Healthcare Inc
HCA
| Msjdxppj | Ztqmgy | $104.1 Bil | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | Mvbswn | $21.2 Bil | |||
| Fresenius SE & Co KGaA
FSNUF
| — | Nbjyrg | $21.2 Bil | |||
| Tenet Healthcare Corp
THC
| Bsjhzbdx | Chpq | $15.6 Bil | |||
| Universal Health Services Inc Class B
UHS
| — | Xnkmf | $15.3 Bil | |||
| Bangkok Dusit Medical Services PCL ADR
BDUUY
| — | Wfkb | $15.0 Bil | |||
| Bangkok Dusit Medical Services PCL Shs Foreign Registered
BDULF
| — | Wzww | $15.0 Bil | |||
| DaVita Inc
DVA
| Fytrcdzyq | Wyhpnf | $13.7 Bil | |||
| Fresenius Medical Care AG
FMCQF
| — | Zkzbq | $12.6 Bil | |||
| Fresenius Medical Care AG ADR
FMS
| Lntbr | Xrfmqr | $12.6 Bil |
United States